Development of Janus Particles as Potential Drug Delivery Systems for Diabetes Treatment and Antimicrobial Applications.
Janus particle
drug delivery
formulation
pharmacodynamics
pharmacokinetics
Journal
Pharmaceutics
ISSN: 1999-4923
Titre abrégé: Pharmaceutics
Pays: Switzerland
ID NLM: 101534003
Informations de publication
Date de publication:
27 Jan 2023
27 Jan 2023
Historique:
received:
15
12
2022
revised:
12
01
2023
accepted:
24
01
2023
entrez:
25
2
2023
pubmed:
26
2
2023
medline:
26
2
2023
Statut:
epublish
Résumé
Janus particles have emerged as a novel and smart material that could improve pharmaceutical formulation, drug delivery, and theranostics. Janus particles have two distinct compartments that differ in functionality, physicochemical properties, and morphological characteristics, among other conventional particles. Recently, Janus particles have attracted considerable attention as effective particulate drug delivery systems as they can accommodate two opposing pharmaceutical agents that can be engineered at the molecular level to achieve better target affinity, lower drug dosage to achieve a therapeutic effect, and controlled drug release with improved pharmacokinetics and pharmacodynamics. This article discusses the development of Janus particles for tailored and improved delivery of pharmaceutical agents for diabetes treatment and antimicrobial applications. It provides an account of advances in the synthesis of Janus particles from various materials using different approaches. It appraises Janus particles as a promising particulate system with the potential to improve conventional delivery systems, providing a better loading capacity and targeting specificity whilst promoting multi-drugs loading and single-dose-drug administration.
Identifiants
pubmed: 36839746
pii: pharmaceutics15020423
doi: 10.3390/pharmaceutics15020423
pmc: PMC9967574
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Références
J Am Chem Soc. 2014 Jun 25;136(25):9116-23
pubmed: 24905667
Langmuir. 2017 Jul 18;33(28):6964-6977
pubmed: 28678499
ACS Appl Bio Mater. 2020 Dec 21;3(12):9054-9064
pubmed: 35019582
Colloids Surf B Biointerfaces. 2018 Oct 1;170:85-91
pubmed: 29894836
Adv Colloid Interface Sci. 2019 Jul;269:256-269
pubmed: 31102800
Front Mol Biosci. 2022 Apr 11;9:865833
pubmed: 35480890
Adv Mater. 2012 Jul 24;24(28):3850-6
pubmed: 22581730
Diabetes Care. 2004 May;27(5):1047-53
pubmed: 15111519
Int J Nanomedicine. 2019 Aug 23;14:6749-6777
pubmed: 31692550
Nanoscale. 2017 Jul 13;9(27):9467-9480
pubmed: 28660946
Adv Drug Deliv Rev. 2021 Sep;176:113788
pubmed: 33957180
ACS Appl Mater Interfaces. 2010 Nov;2(11):3185-91
pubmed: 20979385
Curr Pharm Biotechnol. 2016;17(8):673-82
pubmed: 27033508
Angew Chem Int Ed Engl. 2017 Jul 10;56(29):8459-8463
pubmed: 28471042
Nat Mater. 2019 Feb;18(2):169-174
pubmed: 30510268
Chem Commun (Camb). 2013 Oct 28;49(84):9746-8
pubmed: 24030455
Expert Opin Drug Deliv. 2014 Jul;11(7):1061-74
pubmed: 24811771
Sensors (Basel). 2016 Nov 17;16(11):
pubmed: 27869658
Small. 2020 Nov;16(44):e2004922
pubmed: 33030805
Phys Chem Chem Phys. 2020 Jan 2;22(2):536-548
pubmed: 31834334
Am Health Drug Benefits. 2017 Jun;10(4):197-200
pubmed: 28794823
Chem Mater. 2011 Apr 12;23(7):1985-1992
pubmed: 23729990
Trends Biotechnol. 2013 Jul;31(7):426-34
pubmed: 23755997
ACS Nano. 2011 Feb 22;5(2):1483-94
pubmed: 21204585
Food Res Int. 2015 Dec;78:433-441
pubmed: 28433312
PLoS Negl Trop Dis. 2017 Nov 30;11(11):e0006111
pubmed: 29190739
Small. 2010 Feb 22;6(4):503-7
pubmed: 20108232
Langmuir. 2010 Jun 1;26(11):7843-7
pubmed: 20158227
Chem Rev. 2021 Dec 8;121(23):14349-14429
pubmed: 34609850
J Am Chem Soc. 2016 Sep 14;138(36):11437-40
pubmed: 27548642
Langmuir. 2015 Apr 14;31(14):4054-62
pubmed: 25796963
J Mater Chem B. 2020 Jun 10;8(22):4813-4830
pubmed: 32227036
Biomacromolecules. 2020 Nov 9;21(11):4396-4441
pubmed: 32543173
Exp Biol Med (Maywood). 2019 Oct;244(14):1162-1177
pubmed: 31617755
Lancet Diabetes Endocrinol. 2018 Jul;6(7):527-537
pubmed: 29776895
EBioMedicine. 2018 Apr;30:273-282
pubmed: 29606630
Langmuir. 2012 Mar 6;28(9):4459-63
pubmed: 22251479
Langmuir. 2021 Jul 13;37(27):8167-8176
pubmed: 34176271
Rep Prog Phys. 2018 Dec;81(12):126601
pubmed: 29978830
Small. 2022 Jun;18(24):e2200020
pubmed: 35429137
ACS Appl Mater Interfaces. 2016 Feb;8(7):4303-8
pubmed: 26844695
Macromol Rapid Commun. 2012 Jul 26;33(14):1178-83
pubmed: 22605558
Oncologist. 2021 Apr;26(4):269-273
pubmed: 33465258
Biomaterials. 2011 Mar;32(8):2124-32
pubmed: 21147500
Chem Sci. 2020 May 5;11(20):5323-5327
pubmed: 34122990
Nano Lett. 2019 Mar 13;19(3):1587-1594
pubmed: 30585728
Langmuir. 2022 Jun 7;38(22):6882-6895
pubmed: 35617199
Curr Top Med Chem. 2014 Mar;14(5):676-89
pubmed: 24444159
Diabetes Care. 2009 Nov;32 Suppl 2:S253-9
pubmed: 19875560
Int J Pharm. 2015 Feb 1;479(1):241-51
pubmed: 25529433
Rev Sci Instrum. 2020 Jan 1;91(1):013902
pubmed: 32012602
Mater Today Bio. 2019 Oct 21;4:100033
pubmed: 32159157
Biotechnol Bioeng. 2012 Nov;109(11):2920-31
pubmed: 22615073
Int J Pharm. 2014 Oct 1;473(1-2):304-15
pubmed: 24905777
ACS Sens. 2018 Nov 26;3(11):2261-2268
pubmed: 30350587
Macromol Rapid Commun. 2019 Apr;40(7):e1800801
pubmed: 30570193
Diabetes Care. 2014 Jun;37(6):1499-508
pubmed: 24855154
Proc Natl Acad Sci U S A. 2006 Mar 28;103(13):4930-4
pubmed: 16549762
Langmuir. 2010 Jul 20;26(14):11732-6
pubmed: 20507141
Perspect Clin Res. 2012 Jul;3(3):109-12
pubmed: 23125962
Nanoscale. 2017 May 4;9(17):5404-5407
pubmed: 28426045
Chem Rev. 2013 Jul 10;113(7):5194-261
pubmed: 23557169
Materials (Basel). 2020 Oct 29;13(21):
pubmed: 33138284
ACS Appl Mater Interfaces. 2022 Apr 20;14(15):17968-17974
pubmed: 35394739
Diabetologia. 2020 Oct;63(10):2049-2056
pubmed: 32894315
ACS Appl Mater Interfaces. 2015 Jun 17;7(23):12539-58
pubmed: 25603397
Science. 1992 Apr 24;256(5056):495-7
pubmed: 17787946
RSC Adv. 2018 Apr 30;8(29):16032-16042
pubmed: 35542202
Langmuir. 2013 Apr 30;29(17):5138-44
pubmed: 23565899
Int J Pharm. 2019 Mar 25;559:1-12
pubmed: 30664992
J Am Chem Soc. 2010 Jun 2;132(21):7234-7
pubmed: 20459132
Neuro Oncol. 2011 Jul;13(7):700-9
pubmed: 21727209
Chem Mater. 2017 Feb 28;29:1448-1460
pubmed: 31530969
Eur J Pharmacol. 2021 Mar 5;894:173854
pubmed: 33428898
Sci Rep. 2022 Jul 15;12(1):12157
pubmed: 35840648
J Diabetes. 2019 Jul;11(7):563-572
pubmed: 30520247
Beilstein J Nanotechnol. 2014 Dec 05;5:2346-62
pubmed: 25551063
Sci Rep. 2019 Mar 8;9(1):3918
pubmed: 30850640
Anal Chem. 2021 Oct 19;93(41):13945-13951
pubmed: 34618421
Langmuir. 2008 Sep 16;24(18):10073-7
pubmed: 18715019
Adv Drug Deliv Rev. 2011 Nov;63(14-15):1247-56
pubmed: 21605607
Langmuir. 2019 May 7;35(18):6032-6038
pubmed: 30983356
Eur J Pharmacol. 2018 May 5;826:75-84
pubmed: 29391158
Biomater Sci. 2013 May 2;1(5):486-493
pubmed: 32482012
ACS Appl Mater Interfaces. 2019 Mar 13;11(10):9643-9671
pubmed: 30715834
Carbohydr Polym. 2018 May 1;187:43-50
pubmed: 29486843
Acta Biomater. 2021 Aug;130:423-434
pubmed: 34087438
ACS Nano. 2021 Apr 27;15(4):6147-6191
pubmed: 33739822
Nanomaterials (Basel). 2021 Feb 02;11(2):
pubmed: 33540620
Crit Rev Food Sci Nutr. 2022 Apr 27;:1-12
pubmed: 35475710
Biomacromolecules. 2009 Nov 9;10(11):3089-97
pubmed: 19894765
Sensors (Basel). 2021 Jul 15;21(14):
pubmed: 34300568
Polymers (Basel). 2017 Jun 29;9(7):
pubmed: 30970930
Anal Chem. 2012 Jun 19;84(12):5250-6
pubmed: 22507307
Anal Chem. 2019 May 7;91(9):5660-5666
pubmed: 30986039
Chem Soc Rev. 2012 Jun 7;41(11):4356-78
pubmed: 22531991
Langmuir. 2020 Jun 30;36(25):6880-6887
pubmed: 32050073
ACS Appl Mater Interfaces. 2015 Jul 22;7(28):15395-402
pubmed: 26110779
Nat Commun. 2019 Sep 2;10(1):3936
pubmed: 31477728